Pancreatic Cancer Research

ResearcherUSA Mitchell Cancer InstituteNo recent work listed

Arun Bhardwaj

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103685570. Sources: OpenAlex.

Their work

Papers
14 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 3 papers · 2017: 2 papers · 2018: none · 2019: 1 paper

Papers 14

  1. Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/jgo.2018.07.02↗
  2. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enz… Co-author DOI 10.1038/bjc.2017.18↗
  3. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. Co-author DOI 10.3390/ijms18040779↗
  4. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. Co-author DOI 10.1016/j.canlet.2015.10.028↗
  5. Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer. Co-author DOI 10.1038/srep28446↗
  6. MYB Promotes Desmoplasia in Pancreatic Cancer through Direct Transcriptional Up-regulation and Cooperative Action of Sonic Hedgehog and Adrenomedullin. Co-author DOI 10.1074/jbc.m116.732651↗
  7. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. First author DOI 10.1038/bjc.2015.252↗
  8. Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. Co-author DOI 10.18632/oncotarget.3784↗
  9. p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway. First author DOI 10.18632/oncotarget.2398↗
  10. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer… Co-author DOI 10.2147/ijn.s61949↗
  11. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and… First author DOI 10.1074/jbc.m113.484576↗
  12. CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated ac… Co-author DOI 10.1074/jbc.m112.409581↗
  13. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. First author DOI 10.1093/carcin/bgr223↗
  14. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. First author DOI 10.1371/journal.pone.0021573↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ajay P. Singh · 14 shared papers, 2011–2019 · strength 0.72
  2. Seema Singh · 13 shared papers, 2011–2019 · strength 0.67
  3. Sanjeev K. Srivastava · 11 shared papers, 2011–2017 · strength 0.52
  4. Moh'd M. Khushman · 5 shared papers, 2016–2019 · strength 0.34
  5. Sumit Arora · 7 shared papers, 2011–2016 · strength 0.29
  6. Nikhil Tyagi · 4 shared papers, 2014–2016 · strength 0.22
  7. Girijesh Kumar Patel · 3 shared papers, 2017–2019 · strength 0.22
  8. Mohammad Aslam Khan · 3 shared papers, 2015–2017 · strength 0.20
  9. Mary C. Patton · 2 shared papers, 2017–2019 · strength 0.14
  10. Shafquat Azim · 2 shared papers, 2016–2017 · strength 0.13
  11. Marcus Chuan Beng Tan · 1 shared paper, 2019 · strength 0.07
  12. Sachin Kumar Deshmukh · 1 shared paper, 2016 · strength 0.06
  13. Jayanth Panyam · 1 shared paper, 2014 · strength 0.04
  14. Gary Anthony Piazza · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.